Skip to content

A historical controlled study of the effect of early magnesium sulfate catharsis in the treatment of moderate to severe acute pancreatitis

A historical controlled study of the efficacy of early magnesium sulfate laxation in the treatment of acute pancreatitis

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074044
Enrollment
Unknown
Registered
2023-07-28
Start date
2022-09-15
Completion date
Unknown
Last updated
2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moderate to severe acute pancreatitis

Interventions

Experimental group:According to the guidelines, give standard treatment for pancreatitis, and give 5 bottles of magnesium sulfate for Q4h until the stool is dissolved, and then continue to take oral m
Control group:N/A

Sponsors

Department of Gastroenterology, The Second Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Age 18-75 years old, male or female 2) According to the "Atlanta Classification Standard (Revised Edition)" issued by the International Pancreatic Association in 2012, it meets the diagnosis of AP: abdominal pain, blood amylase, lipase = upper limit of normal value 3 times, abdominal CT has pancreatic edema and other lesions. 3) The time between the onset of symptoms and admission is less than 24 hours 4) Patients have a higher risk of complications: including APACHE II score = 8, Glasgow score = 3, BISAP score = 3, or CRP = 120 mg/L

Exclusion criteria

Exclusion criteria: AP with malignant tumors, pancreatic cancer, serious underlying diseases such as heart failure, liver disease, immune diseases, organ transplantation, blood diseases.

Design outcomes

Primary

MeasureTime frame
Number of days in hospital;The severity of the onset;Indicators of infection;CT severity index;

Countries

China

Contacts

Public ContactHu Kewei

Department of Gastroenterology, The Second Affiliated Hospital of Soochow University

532041281@qq.com+86 137 7301 0707

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026